Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Angiotensin II (5-8) (human, rat, mouse) (trifluoroacetate salt)

  • Zoom
    Angiotensin II (5-8) (human, rat, mouse) (trifluoroacetate salt)
  • Angiotensin II (5-8) (human, rat, mouse) (trifluoroacetate salt)
Cat No: 24739
Biochemicals - Peptides
Cayman

Angiotensin II (5-8) is an endogenous C-terminal fragment of the peptide vasoconstrictor angiotensin II (Item No. 17150).{40805} It inhibits renin (Item No. 10006217) release from rat kidney slices at a concentration of 50 μM and relaxes rat aorta pre...

More
: 1 mg

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Synonyms:
  • L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanine, 2,2,2-trifluoroacetate
Correlated keywords:
  • 896715-73-4 Isoleucylhistidylprolylphenylalanine angII(5-8) 34233-50-6
Product Overview:
Angiotensin II (5-8) is an endogenous C-terminal fragment of the peptide vasoconstrictor angiotensin II (Item No. 17150).{40805} It inhibits renin (Item No. 10006217) release from rat kidney slices at a concentration of 50 μM and relaxes rat aorta pre-contracted with phenylephrine (Item Nos. 17205
18619; EC50 = 0.28 μM).{40806,40805} In vivo, microinjection of angiotensin II (5-8) into the ventrolateral periaqueductal gray (vlPAG) of rats increases mean arterial pressure (MAP) and decreases heart rate (HR) by approximately 2.7- and 3-fold less, respectively, than angiotensin II.{40805} It increases the latency to withdrawal in a tail-flick test and the mechanical withdrawal threshold in an incision allodynia test in rats when administered at a dose of 0.2 nmol into the vlPAG. Angiotensin II (5-8) (0.4 nmol, vlPAG microinjection) reduces the number of entries and time spent in the open arms of the elevated plus maze and increases the mean startle amplitude, a measure of conditioned fear, in response to foot shock.{40807}
Size 1 mg
Shipping dry ice
Molecular Formula C26H36N6O5 • XCF3COOH
SMILES C[C@@H](CC)[C@]([H])(N)C(N[C@@H](CC1=CNC=N1)C(N2[C@H](C(N[C@H](C(O)=O)CC3=CC=CC=C3)=O)CCC2)=O)=O.OC(C(F)(F)F)=O
Molecular Weight 512,6
Formulation A lyophilized powder
Purity ≥95%
Custom Code 3504.00
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : Angiotensin II (5-8) (human, rat, mouse) (trifluoroacetate salt) There are 9 products.

Search